Previous Close | 1.1400 |
Open | 1.1480 |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's Range | 1.1480 - 1.3999 |
52 Week Range | 0.1510 - 1.5600 |
Volume | |
Avg. Volume | 128,919 |
Market Cap | 97.863M |
Beta (5Y Monthly) | 1.33 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Presented updated clinical results from the monotherapy dose escalation and ongoing expansion portions ...
Medicenna Therapeutics Corp. (MDNAF) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).